Cross-Site Scripting Vulnerability in Zirve Nova by Zirve Information Technologies
CVE-2025-0419

4.7MEDIUM

Key Information:

Vendor

Zirve Information Technologies Inc.

Status
Zirve Nova
Vendor
CVE Published:
17 September 2025

What is CVE-2025-0419?

A Cross-Site Scripting (XSS) vulnerability has been identified in Zirve Nova, a product by Zirve Information Technologies. This issue arises from improper sanitization of user input during web page generation, potentially allowing an attacker to inject malicious scripts into web pages viewed by other users. The vulnerability affects versions 235 up to and including 20250131, which may result in unauthorized access to sensitive data or execution of harmful actions on behalf of unsuspecting users.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Zirve Nova 235 <= 20250131

References

https://www.usom.gov.tr/bildirim/tr-25-0260

CVSS V3.1

Score:
4.7
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
High
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

Credit

Berat ARSLAN
JSON
.